Olaf Kinzel

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 7 CIPO patents and 17 EPO patents. Top assignees: Gilead Sciences, Inc., Phenex Pharmaceuticals Ag, Janssen Pharmaceutica Nv. Active years: 2015-2025.

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 72.7

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 17 (Patent Applications = 24)

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 182(Granted Patents)

Company Filing History:

7 out of 946

Gilead Sciences, Inc.

patents

6 out of 11

Phenex Pharmaceuticals Ag

patents

5 out of 2,099

Janssen Pharmaceutica Nv

Phenex Discovery Verwaltungs-Gmbh

patent

Years Active: 2015-2025

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12291523 - LXR modulators with bicyclic core moiety (2025-05-06),

2. 11970484 - LXR modulators with bicyclic core moiety (2024-04-30),

3. 11618747 - LXR modulators with bicyclic core moiety (2023-04-04),

4. 11078168 - Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase (2021-08-03),

5. 10485795 - FXR (NR1H4) binding and activity modulating compounds (2019-11-26),

6. 10301272 - Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] (2019-05-28),

7. 10220027 - FXR (NR1H4) binding and activity modulating compounds (2019-03-05),

8. 10150762 - Trifluoromethyl alcohols as modulators of RORγt (2018-12-11),

9. 10080744 - Thiazoles as modulators of RORγt (2018-09-25),

10. 9938278 - FXR (NR1H4) modulating compounds (2018-04-10),

11. 9861618 - Thiazoles as modulators of RORγt (2018-01-09),

12. 9850236 - Trifluoromethyl alcohols as modulators of RORγt (2017-12-26),

13. 9845319 - Amide substituted thiazoles as modulators of RORyt (2017-12-19),

14. 9820979 - FXR (NR1H4) binding and activity modulating compounds (2017-11-21),

15. 9815851 - Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases (2017-11-14),

Title: Inventor Olaf Kinzel

Introduction: Olaf Kinzel is a renowned inventor based in Heidelberg, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Olaf Kinzel holds several patents in the areas of renewable energy, medical devices, and automotive technology, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation industry, Olaf Kinzel has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Olaf Kinzel has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Olaf Kinzel's passion for pushing the boundaries of technology and his relentless pursuit of innovation make him a key figure in the world of inventors, with a legacy that continues to inspire future generations.